4-Hydroxynonenal (HNE), an electrophilic end-product deriving from lipid peroxidation, undergoes a heterogeneous set of biotransformations including enzymatic and non-enzymatic reactions. The former mostly involve red-ox reactions on the HNE oxygenated functions (phase I metabolism) and GSH conjugations (phase II) while the latter are due to the HNE capacity to spontaneously condense with nucleophilic sites within endogenous molecules such as proteins, nucleic acids and phospholipids. The overall metabolic fate of HNE has recently attracted great interest not only because it clearly determines the HNE disposal, but especially because the generated metabolites and adducts are not inactive molecules (as initially believed) but show biological activities even more pronounced than those of the parent compound as exemplified by potent pro-inflammatory stimulus induced by GSH conjugates. Similarly, several studies revealed that the non-enzymatic reactions, initially considered as damaging processes randomly involving all endogenous nucleophilic reactants, are in fact quite selective in terms of both reactivity of the nucleophilic sites and stability of the generated adducts. Even though many formed adducts retain the expected toxic consequences, some adducts exhibit well-defined beneficial roles as documented by the protective effects of sublethal concentrations of HNE against toxic concentrations of HNE. Clearly, future investigations are required to gain a more detailed understanding of the metabolic fate of HNE as well as to identify novel targets involved in the biological activity of the HNE metabolites. These studies are and will be permitted by the continuous progress in the analytical methods for the identification and quantitation of novel HNE metabolites as well as for proteomic analyses able to offer a comprehensive picture of the HNE-induced adducted targets. On these grounds, the present review will focus on the major enzymatic and non-enzymatic HNE biotransformations discussing both the molecular mechanisms involved and the biological effects elicited. The review will also describe the most important analytical enhancements that have permitted the here discussed advancements in our understanding of the HNE metabolic fate and which will permit in a near future an even better knowledge of this enigmatic molecule.
Introduction
Since its identification, 4-hydroxy-nonenal (HNE), an autoxidation product of unsaturated fats and oils, (at first erroneously described as 4-hydroxy-octenal) [1] has attracted great scientific interest, as demonstrated by the publication of more than 4200 papers since 1980 (source PubMed, setting 4-hydroxynonenal as key word, updated November 2016). Compared to other 4-hydroxyalkenals, HNE is the most extensively studied and reviewed as it was the first one discovered [1] , it represents the main 4-hydroxyalkenal formed during autoxidation of unsaturated fatty acids [2] , it is highly reactive [3] and numerous biological effects have been demonstrated [4] . Besides several papers dealing with its biological properties, great attention has also been paid to the metabolic fate of HNE and to the analysis of the compound as such and of the corresponding metabolites in biological matrices. Such a great interest in metabolism is explained by the fact that, due to its high reactivity, HNE undergoes a rapid disappearance and biotransformation which regulates its free content, thus making the metabolic process an important factor regulating biological activity. Moreover, HNE metabolites are not inactive species but they themselves have potent biological activities as recently found for GSH adducts [5] . Metabolism and bioanalysis are strictly connected because understanding of the metabolic pathways requires the set-up of selective and sensitive on-target and off-target methods for the identification and characterization of HNE metabolites. Hence, metabolism and bioanalysis of HNE are two fields which have in the past and will continue to attract great scientific interest.
As summarized in Fig. 1 , HNE undergoes rapid enzymatic and nonenzymatic biotransformations yielding reversible and irreversible HNE derivatives. Enzymatic HNE detoxification was first described in rat hepatoma cell lines by a seminal paper in 1988 [6] and was later clarified in different cell models and animals both from a qualitative and quantitative point of view. Other 4-hydroxyalkenals, such as 4-hydroxyhexenal (HHE), have the same functional groups than HNE and are detoxified via a similar pathway. Non-enzymatic reactions also represent an important fate of HNE and are widely studied because they are responsible for several of its biological effects. From a general point of view and due to its electrophilic nature, HNE can covalently react through non-enzymatic reactions with nucleophilic substrates and in particular with peptides, proteins, nucleic acids and amino phospholipids [7] . Such extensive enzymatic and non-enzymatic HNE biotransformation regulates the content of the free HNE form which has only recently been analyzed thanks to the advent of more sensitive and selective analytical approaches.
While the enzymatic HNE biotransformation is a well-regulated process, well-explained in terms of metabolic detoxification, the role of the non-enzymatic biotransformations in modulating HNE detoxification is still debated.
The aim of the present review is to give a detailed overview of the enzymatic and non-enzymatic fate of HNE with a particular focus on understanding the biological role of non-enzymatic reactions and on the most modern analytical applications recently proposed for a qualitative and quantitative analysis of metabolites and reaction products. Such methods have in particular given a deeper insight into the nonenzymatic reactions of HNE, whose reaction products are quite difficult to identify and characterize due to their heterogeneity and low abundance. Another relevant aspect, which will be covered in the present review, regards the biological activity of the metabolites which in the past were considered as inactive detoxification products but have recently attracted more interest due to their biological activity.
Enzymatic detoxification
Upon lipid peroxidation of a ω-6 fatty acid HNE is generated as a toxic end product that can react with proteins, DNA and lipids to exert damaging activity. One of the systems the human body deploys to detoxify HNE is phase I metabolism using a variety of redox enzymes, and/or phase II metabolism mostly by conjugation to Glutathione (GSH) (Fig. 2) .
Phase I Metabolism

Oxidation
HNE can be readily oxidized by different enzymes to 4-hydroxynonenoic acid (HNA), such as aldehyde dehydrogenases (ALDH) ( Table 1) (Fig. 2) . Different isoforms of ALDH have been described to oxidize the HNE carbonyl group, among which ALDH1A1, ALDH2 and ALDH3A1 are the most studied ones [8] .
Many papers have been published on the role of ALDH enzymes in various different pathologies and on the protective effect they might have towards HNE cytotoxicity, thus underlying the relevance of such pathway in HNE detoxification. These protective roles were found after overexpression of these enzymes or using activator molecules. A short summary of recent papers will be outlined below.
A new model of age-related cognitive impairment to study Alzheimer's disease (AD) was proposed in ALDH2 (-/-) mice, which showed an increase of HNE adducts in the hippocampi and pathological changes that correlate with AD [9] . Other pathologies in the brain have also been associated with HNE and ALDH metabolism as exemplified by the ALDH2 rs671 A allele, which induces higher levels of HNE and which is associated with post-stroke epilepsy susceptibility [10] . Overexpressing this enzyme was shown to partially restore activity. Furthermore, the ALDH agonist Alda-1 successfully activated ALDH2 in a rat model of focal cerebral ischemia/reperfusion injury, decreased the accumulation of HNE and malondialdehyde (MDA), and improved brain injury [10] . ALDH2 activation could also prevent endothelial injuries induced by amyloid β peptides, which are responsible for mitochondrial dysfunction and cause cerebral degeneration [11] . Moreover, a neuroprotective effect of ALDH2 was found to be able to detoxify HNE both in vitro and in vivo [11] .
HNE has also been involved in heart diseases and studies have shown protective roles of ALDH2, as confirmed by the capacity of Alda-1 to significantly decrease aldehydic load in failing hearts [12] . The underlying mechanism of decreased mitochondrial ALDH2 activity was elucidated using murine models and an anoxia model of cardiomyocytes. Induced levels of HNE were observed after decreased ALDH2 activity that led to apoptosis of cardiomyocytes by inhibition of HSP70, phosphorylation of JNK, and activation of p53 [13] . Furthermore, the ALDH3A1 gene expression was significantly decreased in Wistar rats after administration of Doxorubicin (DOX), a chemotherapeutic agent with cardiotoxicity as a side effect mediated by oxidative stress and upregulation of HNE [14] . Another study on the effect of DOX showed a decrease in accumulation of HNE after treating mice with Alda-1 [15] .
ALDH2 activated by Alda-1 was also successfully able to inhibit atherosclerosis and to attenuate nonalcoholic fatty liver disease (NAFLD) in mice [16] . Moreover, a high dose of ethanol leads to inhibition of ALDH2 in rats and increased levels of HNE and MDA were found in the serum [17] . Lastly, the effects of ethanol on gastric mucosa injury and the beneficial role of the antioxidant lipoic acid as activator for ALDH2 was studied [18] . Acute administration of ethanol induced injury in the gastric mucosa and increased levels of HNE, together with a reduced activity of ALDH2. When lipoic acid or Alda-1, used as positive control, were given before ethanol treatment, the detrimental effects of ethanol were prevented. The mechanism still needs to be elucidated. These results regarding HNE protection are truly promising especially as lipoic acid is a natural compound and can be easily given as a dietary supplement.
HNE has been implicated in many different diseases, and the effect HNE might have can be counteracted by inducing the metabolism. Numerous promising results have been described regarding ALDH enzymes and progress is being made.
HNA is not the final metabolite after oxidation of HNE, as it is able to undergo β-or ω-oxidation (Fig. 2) . In the early nineties water and CO 2 were found as secondary products of HNE metabolism, and were ascribed to β-oxidation [19] as later demonstrated by Li et al. in 2013 [20] . They showed that this pathway may be inhibited in ischemic rat heart and contributes to pathology since it increases the HNE concentration and the resulting protein modifications.
ω-Oxidation was first demonstrated by Alary et al. in 1998 , where HNA is oxidized to 9-hydroxy-HNA, further oxidized by ADH and ALDH to 9-carboxy-HNA [21] , later demonstrated in liver slices [22] . Also HNA-lactone, described further in this review, is available for microsomal ω-hydroxylation by cytochrome P450 4A enzymes [23] . More recently, it was shown that the same enzyme further catalyzes the ω-/ ω-1-hydroxylation of HNA in a perfused rat liver to 4,9-dihydroxynonanoic acid and 4,8-dihydroxynonanoic acid [24] and that a ketogenic diet stimulated this process, resulting in lower HNE levels.
Reduction
Besides oxidation of the carbonyl group of HNE, it is also possible to be reduced to the alcohol 1,4-dihydroxynonene (DHN) via alcohol dehydrogenase (ADH) or aldo-keto reductase (AKR) enzymes (Table 1 ) ( Fig. 2) . ADH is a NADH dependent enzyme mainly found in the hepatic cytosol; its main function is to break down alcohols, but different isozymes have been described to show activity towards aldehydes in rats [25] . Thus far, this family of enzymes have not been extensively studied in humans and more information is needed in order to understand the metabolic relevance of these enzymes in the detoxification of HNE.
A second group of enzymes is the aldo-keto reductase superfamily, with 15 human isozymes related to pathologies and a few have been described to detoxify HNE [26, 27] . Among these, AKR1B10 catalyzes the NADPH-dependent reduction of HNE to its corresponding alcohol, DHN, but also the reduction of the glutathionyl conjugate. Other isoforms, like AKR1B1, have been found to have more activity towards glutathionyl conjugates than towards free HNE [28, 29] . HNE contributes to colorectal cancer (CRC) and different metabolites of HNE have been reported. AKR1B10 expression is diminished during carcinogenesis of the colon and increases the levels of HNE and acrolein contributing to the disease [30] . Controversially, another study showed that GSTA4 is activated during CRC, which aids the detoxification of HNE [31] .
AKR1C1 and AKR1C2 are almost identical enzymes and both are found to be able to reduce HNE [32] . AKR1C3 has also been shown to reduce HNE in human neuroblastoma SH-SY5Y cells and to protect them from aldehyde toxicity as a model for neurodegenerative diseases [33] . Moreover, members of the AKR6 and AKR7 family have shown activity towards reactive aldehydes, like HNE.
Another enzyme described is alkenal/one oxidoreductase (AOR) which is able to reduce the C2-C3 trans double bond (Table 1) (Fig. 2 ) [34] . This enzyme is NAD(P)H-dependent and is also known as leukotriene B 4 12-hydroxydehydrogenase or 15-oxoprostaglandin 13-reductase. Recent studies showed a significant protective effect of cells overexpressing AO against HNE.
Furthermore, retinol dehydrogenase 12, RDH12, was shown to detoxify HNE to the corresponding alcohol in photoreceptor cells in a NADPH dependent matter (Table 1) [35] .
Unlike the oxidation of HNE, the reduction has not been investigated relating to different pathologies and an effort should be made to discover protective roles of this metabolic pathway in order to offer more options against HNE cytotoxicity.
Oxidation and reduction
Finally, phase I metabolism includes both the reduction and oxidation of the carbonyl group on HNE yielding either DHN or HNA by the enzymes of the Cytochrome P450 (CYP) family (Table 1) (Fig. 2 ) [36, 37] . Different human CYPs, CYP2B6, CYP3A4, CYP1A2 and CYP2J2, were found to be able to reduce the aldehyde using HPLC. It was suggested that the oxidation state of CYPs influences the product that is generated. HNE is oxidized in the presence of perferryl or ferric peroxide CYP, oxygen and NADPH, whereas it is reduced by ferrous CYP and in the presence of NADPH. To this date, no studies have described a protective role of this family of enzymes.
Phase II metabolism
Glutathione conjugation
To date, the only enzyme-catalyzed phase II reaction that has been characterized for HNE is its conjugation with glutathione to give 3-(sglutathionyl)-4-hydroxynonanal (GS-HNE), which has been known since the nineties as a primary metabolite of HNE (Table 1) (Fig. 2 ) [38] . As explained in Fig. 2 , since the GSH Michael addition removes the trans C2-C3 double bond, GS-HNE exists in equilibrium between the free aldehyde and its cyclic hemiacetal [7] . The enzymes catalyzing GSH conjugation belong to the alpha class glutathione S transferase family (GSTs), which play an important role in the detoxification of electrophiles. The activity of mouse liver GSTs towards HNE has been known since the nineties [39] and in the same decade an isoform with high HNE specificity (GSTA4) was characterized [40] . Mouse liver GSTA4 was also found to be inducible by HNE as demonstrated by confocal immunofluorescence microscopy experiments [41] .
The role of GSTs is to catalyze the Michael addition of GSH to the electrophilic β carbon atom of HNE, making this reaction faster than the spontaneous Michael addition [40, 42] . Such a reaction does not take place after HNE phase I metabolism, since both reduction and oxidation produce non-reactive primary metabolites [23] . On the other hand, secondary metabolites deriving from phase I metabolism of GS-HNE have been identified by several authors, in particular the 3-(sglutathionyl)-1,4-dihydroxynonane (GS-DHN) and the 3-(s-glutathionyl)-4-hydroxynonanoic acid (GS-HNA), which is able to undergo an intramolecular reaction to generate the corresponding cyclic lactone (GS-HNL) (Fig. 2) [23, 43, 44] .
Interestingly, Alary et al. demonstrated that both GS-HNE and GS-HNL undergo spontaneous retro Michael reactions, generating HNE and cis-HNA lactone (HNL), respectively. The same authors also demonstrated that HNL is more electrophilic than its open form (HNA) and therefore is able to react with GSH. They also demonstrated that GSTs are HNE selective, since purified rat liver GSTs catalyze GS-HNE retro Michael reaction but not HNL Michael addition to GSH or GS-HNL retro Michael [23] .
After GSH conjugation to HNE, this intermediate is still very active and can be either reduced or oxidized (Fig. 2) . Well described pathways include the NADPH dependent reduction to GS-DHN by an aldose reductase [28] . GS-HNE can also be oxidized by a NAD + dependent aldehyde dehydrogenase to 4-hydroxynonanoic acid-glutathione (GS-HNA) [45] or GS-HNA-lactone [23] . Additionally, a new role for the carbonyl reductase 1 (CBR1) enzyme has been described since it can catalyze both reactions of GS-HNE (Table 1) [46, 47] . This enzyme is only reactive to GS-HNE, and not to HNE due to the glutathionyl moiety, as confirmed by its activity towards 3-glutathionyl-nonanal, 3-glutathionyl-hexanal and 3-glutathionyl-propanal. CBR1 is able to reduce GS-HNE in its hemiacetal form to GS-HNL in a NADP + -dependent manner [46] , and to oxidize the free aldehyde to GS-DHN in a NADPH-dependent manner [47] . Furthermore, CBR1 is able to convert GS-HNA to glutathionyl-4-ketononanoic acid (GS-ONA) [46] . These results have only been shown in vitro, and more studies are necessary to evaluate its activity in vivo. However, as summarized in Fig. 2 , GSH conjugates are not the final metabolites of HNE disposal. In fact, it is known that such conjugates can be further metabolized and excreted as mercapturic acids (HNE-MA, HNA-MA and DHN-MA) [48] . The pathway leading to this biotransformation is common across all GSH conjugates (GS-HNE, GS-HNA or GS-DHN). The first step is the removal of gamma-glutamate operated by gamma-glutamate transferase (GGT) [49] , followed by the removal of glycine catalyzed by a heterogeneous set of dipeptidases including dehydropeptidase I, aminopeptidase M or aminopeptidase N and cytosolic non-specific dipeptidases. Nevertheless, a specific cytosolic dipeptidase for cys-gly S conjugates was described as an essential enzyme in the mercapturic route of rat liver [50] . The last step of the metabolic pathway is the N-terminus acetylation catalyzed by the enzyme cysteine S-conjugate N-acetyltransferase (CCNAT) [51, 52] , which only recently have been identified as the enzyme encoded by the gene NAT8 (Table 1 ) [53] .
Putative phase II metabolites from uncharacterized pathways
Two glutathione-HNE 4-oxo-conjugates, namely 3-(S-glutathionyl)-4-hydroxynonanal (GS-ONE) and 3-(S-glutathionyl)-4-oxononanol (GS-ONO), were also identified as HNE metabolites of keratinocytes incubated with HNE (Fig. 3C) [54] . They possibly arise from oxidation of the 4 hydroxyl moiety of GS-HNE and GS-DHN, respectively, but the metabolic pathway of their production is still unclear.
Mercapturic acids have been found also for a set of ω-oxidized HNA derivatives (Fig. 3A) [23, 55] . Alary and colleagues proposed a reaction scheme predicting the reaction of ω-oxidized HNA with GSH through a Michael reaction [23] . However, since HNA has been proven to be nonelectrophilic [23] it is not clear how its ω-oxidation derivatives can react with GSH.
A more realistic pathway for the production of such metabolites could occur through the following steps:
1. ω-Oxidation of HNL to produce 4,9 dihydroxy-nonenoic acid lactone (DHNL) and 9 carboxy 4-hydroxy-nonenoic acid lactone (CHNL) 2. Formation of the glutathione conjugates GS-DHNL and GS-CHNL through a Michael reaction between GSH and either DHNL or CHNL, as already observed for HNL 3. Conversion of GS-HHNL and GS-CHNL into the corresponding mercapturic acids (HHNL-MA and CHNL-MA, respectively, Mercapturic acids have been reported also for ω-oxidized HNE (CHNE-MA, Fig. 3B ) and ω-oxidized DHN (CDHN-MA, Fig. 3B ) [55] . Also in these cases, there are no hypothesis on how they can be produced.
Although GSH conjugates are the only phase II metabolites of HNE that have been fully characterized, the recent identification of two glucuronides (i.e. DHN-GCN and HNA-GCN, Fig. 3D ) suggests that HNE metabolism can include other phase II reactions [55] . However, to date there are no clues relating such metabolic pathways, nor to the mechanisms leading to the production of three other metabolites assigned as 3-methylsulfanyl derivatives of 4-hydroxynonenoic acid (i.e. TM-HNA, TM-DHNA and TM-CHNA, Fig. 3E ) [55] .
Other metabolites identified from uncharacterized pathways are phase I metabolites [55] . Fig. 3F represents a group of metabolites in which HNE undergoes oxidation and a reduction of the C2-C3 trans double bond. It remains unclear whether 4,8,9-trihydroxy-nonanoic acid (THN) and 9-Carboxy-4-oxo-nonenoique acid (CHN) derives from the oxidation of HNA and then a reduction of the C2-C3 trans double bond, or vice versa. The proposed pathway for γ-nonalactone (NL) is a reduction of the double bond, followed by an oxidation step and lactonization [56] . The same author identified another metabolite of HNE, 4-oxononenal (ON) [57] . However, this pathway still needs to be determined.
Finally, two more putative metabolites that are oxidized, but not conjugated (Fig. 3G) , have been identified [55] . To date, the pathways leading to 9-hydroxy-4-oxo-nonenoic acid (HONA) and 9-carboxy-HNE (CHNE), have not been characterized yet.
Quantitative aspects of HNE phase I and phase II metabolism
To elucidate the fate of HNE, either metabolized by phase I or II metabolism or adducted to molecules or macromolecules, many studies have been published on the quantification of HNE disposal. Experiments with tritiated HNE confirm that only a small percentage of radioactivity can be found on proteins or DNA, confirming that the vast majority of HNE disposal is due to metabolism. In particular, the percentage of HNE found on proteins was reported to be around 5% of the total HNE dose in rat liver and brain [58] . A similar amount was found in human polymorphonuclear leukocytes incubated with HNE [59] and a percentage between 2% and 8% was found in various mammalian cells and organs such as hepatocytes, intestinal enterocytes, renal tubular cells, aortic and brain endothelial cells, synovial fibroblasts, neutrophils, thymocytes, heart, tumor cells [60, 61] and rat kidney cortex mitochondria [62] . Interestingly, pathologies like dia-betes can negatively influence the activity of some metabolism enzymes such as GST and ALDH, while ADH activity remains unchanged [63] . Not all tissues have the same metabolic capacity and although NADH stimulated HNE metabolism reduced protein adducts in rat liver (but not in lung or brain) it seems impossible to metabolically prevent protein-HNE modification [64] .
The metabolism of HNE seems to be very fast. In rat kidney cortex mitochondria, 80% of tritiated HNE is metabolized within 3 min producing DHN, HNA and GSH conjugate [62] . In hepatoma cell a dose of 25 µM HNE has a half-life of 2 min and 75% is converted into either GSH conjugates (61%) or HNA (14%), while a small percentage follows the tricarboxylic acid pathway [65] . In hepatocytes, a 100 µM HNE dose is metabolized within 3 min and accompanied by a decrease of free GSH, which is followed by its restoration in a S shaped curve up to concentrations below the initial value [61] . In serum, the physiological HNE level (about 0.1-0.2 µM) as measured by means of GC techniques was restored after 10-30 s, starting from an initial value of 1 µM HNE [61] . However, data on basal HNE level are inconsistent since antibody detection estimates a concentration of about 600-700 nM in serum of healthy subjects and diabetics [66] .
Also the equilibrium between phase I and phase II metabolism seems to be influenced by the organ or cell type. For instance, many cells type are not able to convert GSH conjugates into the corresponding mercapturic acids [61] .
Experiments in rat aortic smooth muscle reveals that 60% of the metabolism is linked to GSH conjugation, GS-DHN being the major metabolite [29] . Aldose reductase was the enzyme responsible for GS-HNE reduction since GS-DHN formation was prevented by the addition of a specific enzyme inhibitor. The same paper also demonstrated that 25-30% of HNE was oxidized to HNA by ALDH, since the addition of a ALDH inhibitor prevented HNA formation. Decrease of HNA was accompanied by an increase of GSH conjugation revealing that the two pathways are in competition for HNE detoxification.
Similar percentages of adducts were found in rat erythrocytes [67] but inhibitors of aldehyde or alcohol dehydrogenase (i.e. cyanamide and 4-methyl pyrazole) had no effect on the formation of HNA and GS-DHN, indicating that these enzymes are not significantly involved in the erythrocyte HNE metabolism. However, aldose reductase inhibition led to a selective decrease in the formation of GS-DHN. Nevertheless, the extent of GSH conjugation was unaffected suggesting that inhibition of GS-HNE phase I metabolism does not have a negative feedback on phase II metabolism.
After 2 min, the approximate distribution of HNE metabolites in rat hepatocytes was found to account for about 30% HNE-GSH adduct, 30% HNA, 10% DHN, while the remaining 30% of HNE followed other metabolic pathways. A key role of the β-oxidation pathway in the disposal of tritiated HNE was confirmed since water radioactivity decreased after addition of a β-oxidation inhibitor [22, 60] .
Leukocytes are also able to metabolize about 20% of radiolabeled HNE by β-oxidation, while mercapturic acids and proteins account for only 5% of the total radioactivity. Interestingly, HNA was found to be the main metabolite followed by DHN and GSH conjugates [59] .
Unlike liver, where mercapturic pathway seems to prevail, oxidation pathways seems to be the principal responsible for HNE metabolism in the brain [58, 68] . Experiments in astrocytes revealed that 90% of a 1 µM initial dose of HNE was metabolized into the expected metabolites (HNA, GS-HNE, GS-DHN) with a prevalence of oxidation products (HNA). However, an increase of the HNE initial dose decreased the percentage of HNE metabolized either as HNA or GSH conjugates [57] . A minor role of GSH conjugation in total HNE metabolism has recently been found in various rat organs [69] .
Transport and excretion of HNE metabolites
Although not investigated as deeply as phase I and phase II metabolism, excretion of HNE metabolites is a relevant process to HNE disposal. Dygas et al. reported that GS-HNE conjugate can be transported by the human erythrocyte multispecific organic aniontransporting ATPase (MOAT) [70] . Interestingly, evidence of enterohepatic circulation of HNE metabolites has been obtained in rats after intravenous infusion of radiolabeled HNE [71] . The HNE metabolites GS-HNE, GS-DHN, DHN-MA and HNL-MA were detected in bile, while urine contained only mercapturic acids (i.e. DHN-MA, HNL-MA, HNE-MA and HNA-MA). The multidrug resistance-associated protein 2 (MRP2) transporter has been identified to be GS-HNE specific in rat hepatocytes. In fact, hepatocytes from MRP2 deficient rats have a fourfold diminished ability to export GS-HNE in the extracellular media compared to hepatocytes from wild-type rats. However, the extracellular concentration of HNA (the other main HNE metabolite detected) was the same for the hepatocytes of both control and MRP2 deficient rats [72] . Also RLIP76 seems to be involved in the transport of HNE and its conjugates since excised liver tissue from RLIP76 deficient mice accumulates HNE and GS-HNE at concentrations three times higher than control [73] . Notably, since transport activity of RLIP76 mediates insulin resistance by increasing the clathrin-dependent endocytosis of insulin, one may argue that the role of this transporter in modulating the insulin resistance during oxidative stress conditions goes beyond excretion of HNE metabolites (PMID: 20007934).
Enantioselectivity of phase I and phase II reactions
Since HNE has a stereocenter (C4) and naturally occurs as a racemic mixture of (S)-HNE and (R)-HNE [74] , the enantioselectivity of the enzymes involved in HNE metabolism has been studied by several authors.
For phase I metabolism, Honzatko et al. published two studies reporting enantioselectivity regarding ADH and ALDH enzymes. Both in the rat liver cytosol and guinea-pig liver cytosol (R)-HNE was metabolized more efficiently than the (S)-enantiomer [75, 76] . Interestingly, in the rat liver cytosol ADH was found to be enantioselective, and ALDH showed little difference, whereas ALDH was shown to be enantioselective in guinea-pig liver cytosols. ADHs in guinea-pig liver cytosols were inactive against both HNE enantiomers. Another study, performed in rat brain mitochondria, also showed a preferential detoxification of (R)-HNE by ALDH using a novel method for the separation of (R)-HNE and (S)-HNE by a derivatization technique [77] . Same results were found in brain mitochondrial lysates, where rat ALDH5A showed a preference for (R)-HNE, however rat ALDH2 did not seem to be enantioselective [78] .
GSTs enantioselectivity has been studied by several scientists who have published inconsistent results. In fact, while some authors reported that GST is not enantioselective [77] or perhaps slightly enantioselective [79] [80] [81] , others have reported that GST selectively produces (S)-HNE [76] .
In an animal experiment Gueraud et al. demonstrated that, for both HNE enantiomers, about 40% of the radioactivity originating from intravenous infusion of tritiated HNE is excreted into urine as mercapturic acids (see Table 2 ) [43] . (R)-Enantiomer was metabolized more rapidly since residual (R)-HNE was less than (S)-HNE. Moreover, urinary excretion of DHN-MA was higher for rats receiving (R)-HNE. This demonstrates that the enzymes catalyzing the conversion of GS-HNE into GS-DHN are enantioselective. However, the authors have not reported that the enzymes catalyzing the oxidation of the HNE glutathione conjugates are not enantioselective since the sum of the radioactivity for end-products of oxidative metabolism (HNL-MA + HNA-MA) is almost equal for both enantiomers. However, according to the data reported in Table 2 , (S)-HNE produces more HNL-MA. This suggests that the GS-HNA/GS-HNL equilibrium reported in Fig. 2 is influenced by the configuration of the C4 carbon atom.
In the same paper the authors also tried to track the metabolic fate of the two enantiomers of GS-HNE incubated in rat liver cytosol, by quantitating the main products of oxidative and reductive metabolism of GS-HNE, along with GS-HNE retro Michael products. Data are reported in Table 3 and suggest that GS-(S)-HNE is metabolized and undergoes retro Michael reaction more than GS-(R)-HNE. However, the identified metabolites of GS-(R)-HNE accounted for more than 90% of initial radioactivity, while only 66% of the initial radioactivity was retained by the corresponding GS-(S)-HNE metabolites. This suggests that the higher metabolic rate observed for GS-(S)-HNE is due to some uncharacterized enantioselective pathways. Interestingly, by monitoring GSH adducts in various rat organs, Sadhukhan et al. found (S)-enantioselectivity for liver and heart, whereas brain metabolism was not enantioselective [69] . Taken together, these data demonstrate that GSTs selectivity can be organ dependent, probably due to the high GSTs polymorphism [82] . Therefore, it is not surprising that different authors can find apparently inconsistent data about GSTs enantioselectivity in experiments utilizing different animal models or different cell type/ organs.
Analytical aspects of HNE metabolism tracking
Detecting HNE metabolites has proven to be quite challenging, but advancements have been made in recent years leading to the identification of metabolites and their formation. Basic analytical aspects of HNE metabolite analysis have recently been reviewed by Spickett [83] . Since the nineties, some analytical efforts have been focused on developing more sensitive methods for detecting HNE metabolites in biological specimens collected from cells, tissues or animals. Early methods were based on derivatization reactions aimed at increasing the sensitivity of UV [38] , fluorometric [84] or electrochemical [85] detection of the analytes after their chromatographic separation.
Although some efforts have been made also on the development of enzyme immunoassays [86] , mass spectrometry (MS) is nowadays the preferred detection technique since it is suitable for quantitation and allows the simultaneous identification even of unpredicted/new metabolites. This technique can be coupled either to gas chromatography (GC-MS) or liquid chromatography (LC-MS).
The use of GC-MS for the determination of TMS-derivatized HNE has been known since the nineties [87] and is still used for tracking HNE metabolism [88] . Concerning other modern GC based approaches, Asselin et al. described a method based on a Raney nickel reaction to convert HNE conjugates into corresponding alkanal, alkanol or acid derivatives (i.e. 4 hydroxynonanal, 1,4 dihydroxinonane, 4 hydroxynonanoic acid) followed by GC detection [89] . Moreover, an interesting method for incorporation of different number of deuterium atoms into Table 2 Percentages of the initial radioactivity for urinary metabolites detected after 48 h. Reelaborated data in bold, HNA lactone reported as HNL. Data taken from Gueraud et al. [43] . HNE metabolites was proposed by Li et al. [90] . The method is based on NaBD 4 reduction followed by TMS derivatization and GC-MS analysis. The reduction step leads to incorporation of no deuterium atom for DHN, one deuterium atom for HNE and two deuterium atoms for ONE, making the corresponding metabolites easy to distinguish by mass spectrometry. The importance of isotope labeling for mass spectrometry detection of HNE metabolites has been discussed by Sadhukhan et al. [91] and a clear example of how to use this technique to track complex metabolic pathways has been given by Zhang et al. [92] .
Metabolite (R)-HNE (S)-HNE
Importantly, also LC-MS based protocols can include isotope labeling or derivatization steps. Derivatization can be used to enhance the sensitivity of MS detection by increasing ionization efficiency of the analytes [93] or for other purposes. For instance, the use of chiral reagents has been demonstrated to be a powerful tool to chromatographically resolve enantiomers and to reveal the enantioselectivity of enzymes involved in specific metabolic pathways [77, 94] .
Among the applications using isotope labeling, a first application that is worthy of mention is the use of stable isotope tagged HNE. This reagent allows the detection of unpredicted metabolites by MS, fishing out signals with a peculiar isotope pattern [95] .
A second application of isotope labeling that has been widely used to track HNE metabolic fate is the use of radiolabeled HNE. By using this technique, it is possible to measure the percentage of residual radioactivity in the different body or cell compartments, which is a quantitative index of the disposal of the initial dose of radiolabeled HNE. The most used reagent is tritiated HNE ( 3 H-HNE) which has been used by many authors since the nineties [21, 22, 29, 43, 71, 96, 97] . Notably, these two isotope labeling strategies have recently been merged to allow a comprehensive characterization of HNE metabolism after oral administration of HNE in rats [55] . Finally, sample treatment before LC-MS analyses has been a recent matter of concern. In fact, Sadhukhan et al. demonstrated that GS-HNE content can be overestimated since residual glutathione and residual HNE can react through a non-enzymatic Michael reaction. This issue was addressed by the authors who suggest spiking the samples with iodoacetic acid to quench the residual GSH activity [69] .
Biological activity of phase I and II HNE metabolites
In general term, metabolism transforms lipophilic compounds into more polar, hydrophilic and readily excretable products. Phase I and II HNE metabolites fulfil this general rules since all the HNE metabolites are more hydrophilic in respect to the parent compound. Although HNE metabolites are less electrophilic in respect to HNE or not reactive at all, some of them have a biological activity which is potentiated in respect to the parent compound. In this regard, some studies have evaluated the biological activity of HNE metabolites with a particular interest on phase II metabolites. Spite et al. have found that GS-HNE is a potent proinflammatory stimulus in vivo and that it has also direct action on isolated human leukocytes [98] . In particular GS-HNE when injected intraperitoneally (1 µg) induced a significant infiltration of leukocytes, within the range of that stimulated by LTB4 and fMLP which was 10-fold higher than that evoked by HNE and by the reduced GSH-HNE metabolite (GS-DHN). By contrast, GS-DHN was found to induce inflammation in macrophages [99] and mitogenic signaling in smooth muscle cells [99] . A further confirm on the role of GS-HNE and GS-DHN as pro-inflammatory agents is given by the experiments in RLIP76 knockout mice in which the export of glutathione metabolites is blocked. These mice were found to be protected against inflammation and, notably, from oxidative stress-induced insulin resistance [99] . More recently a novel mechanism involving GS-HNE and GS-DHN in obesity-induced metabolic syndrome has been reported. GS-HNE and GS-DHN were found more abundant in visceral adipose tissue of ob/ob mice and diet-induced obese in respect to lean controls and able to induce the expression of inflammatory genes, including C3, C4b, c-Fos, igtb2, Nfkb1, and Nos2. These data can explain the obesity-induced decrease in the GSTA4 expression as a compensatory response, and in particular that downregulation of GSTA4 could be considered as an adaptive mechanism aimed to decrease the inflammatory cascade induced by GS-HNE and GS-DHN. The mechanism by which GS-HNE and GS-DHN transmit their message to the macrophages is yet unknown, but a cell surface receptor would seem to be most likely, such as toll-like receptors (TLRs), potentially TLR6 or TLR9, both of which show upregulated expression in response to GS-HNE and GS-DHN [5] .
Non-enzymatic detoxification
Besides the enzymatic metabolism, HNE degradation involves a set of covalent reactions which, at least in their starting phase, occur without enzymatic processes. HNE is indeed an electrophilic compound which can spontaneously react with nucleophilic moieties within biomacromolecules such as proteins and nucleic acids as well as within small endogenous compounds such as phospholipids and peptides (Fig. 1) . The marked electrophilicity of HNE is ascribable to the conjugation between the carbonyl function and the unsaturated bond which reflects in two distinct reactive centres, namely the carbonyl carbon atom and the unsaturated β-carbon atom [100] . According to hard-soft acid-base theory (HSAB), the nucleophilic reactants can be grouped depending on their preferential reactivity towards the carbonyl group (such as hydroxyl functions), the β-carbon atom (such as thiol functions) or on their capacity to condense with both electrophilic centres (such as amino groups) [101] .
The condensation between the HNE carbonyl function and primary amino groups (such as that characterizing the lysine side chain) involves an initial carbinolamine intermediate followed by a dehydration reaction to give the imino adduct, which is reversible in presence of water molecules and thus is reasonably stable in physiological conditions only when surrounded by very hydrophobic environments (Fig. 4 ) [102] . Again, the condensation on the β-carbon atom (such as that involving the thiol function of the cysteine residue) occurs through Michael addition, the products of which also are reversible and can liberate the nucleophilic group in presence of an excess of a second nucleophilic reactant (Fig. 4) [103] . This renders the Michael adducts more stable in physiological conditions compared to the condensation products involving the carbonyl groups even though they remain reversible and such a reversibility can have relevant biological implications as detailed below.
While avoiding a systematic analysis of all proteins, the HNEinduced carbonylation has been reported in literature, the general reactivity of HNE towards biological targets and the main pathophysiological implications of the adducts will be discussed in the following sections. The reader interested in more comprehensive analyses can refer to recent extended reviews (e.g. see ref. [104] ).
Protein adducts
HNE induced protein carbonylation: general aspects
HNE reacts with nucleophilic residues within proteins, such as the side chains of cysteine, lysine and histidine, mostly yielding the corresponding Michael adducts. As detailed above, the primary amino group of the lysine side chains can also give imino adducts which are reasonably stable when formed within hydrophobic environments (see above), while the formation of thioacetal derivatives has a negligible role in determining the reactivity of the cysteine thiol function (Fig. 4 ) [105] . Several studies have highlighted that HNE-induced protein carbonylation is a highly selective process since very few nucleophilic residues are carbonylated within each protein while the remaining nucleophilic sites appear to be stably unreactive. Despite the great interest attracted by the HNE-induced carbonylation, the reasons for such selectivity are still debated even though accessibility and nucleo-philicity of a given residue appear to play a pivotal role. This means that the residue reactivity is finely modulated by the protein environment and this implies that the dynamic behavior of the protein structure can largely influence the susceptibility of a given residue to carbonylation processes [106] .
A meaningful example of the factors influencing the residue's reactivity is offered by human albumin, the unique free cysteine of which (Cys34) shows a remarkable reactivity towards HNE which can be rationalized by considering both the surrounding residues and its dynamic behavior. Indeed, Cys34 is contacted by three residues (namely His39, Lys41 and Tyr84) which are able to both increase Cys34 nucleophilicity and stabilize the so formed thiolate anion through a mechanism which brings to mind that seen in GST enzymes (Fig. 5) [107] . Moreover, molecular dynamics (MD) studies showed that the thiolate anion induces a set of protein conformational shifts which increases Cys34 accessibility forming a hydrophobic crevice well suited to accommodate HNE as confirmed by docking simulations [108] . As expected, accessibility and nucleophilicity play a key role and appear to be markedly influenced by dynamic processes able to enhance Cys34 reactivity. This can explain the difficulty in developing provisional approaches able to discriminate between reactive and unreactive nucleophilic residues based on the protein amino acidic sequences or, at most, on the protein 3D (static) structures [109] .
A third factor which can influence the residue reactivity is the so called neighboring effect, since regions rich in nucleophilic residues are found to be more susceptible in multiple protein carbonylation probably as the generation of a first protein adduct can enhance the reactivity of the neighboring nucleophilic residues. The recently reported carbonylation of the human ubiquitin provides an interesting example of such a neighboring effect since the marked reactivity towards HNE of His63 can be explained by considering the catalyzing effect exerted by adjacent Lys6 which was found to yield the imino adduct (Fig. 6) [110] . Indeed, one may suppose that there is a cross-talk between these two residues since the imino adduct on Lys6 retains the capacity to yield the Michael adduct and, more importantly, constrains the reactive electrophilic β carbon atom close to the imidazole ring of His63 in a pose stably conducive to the addition. Such a mechanism, which gained experimental confirmation in the acetylation of ubiquitin [111] , highlights the major differences between the HNE-induced protein adducts since the reactions which involve a Michael addition switch off the HNE reactivity forming adducts which are reversible but no longer electrophilic, while the imino condensation exerts only a sort of physical trapping of HNE giving reversible and still electrophilic adducts. Their reactivity and lability suggests that the imino adducts can also act as intermediates to promote the condensation with neighboring histidine or cysteine residues through a mechanism which resembles that observed for carnosine (see below).
Biological effects of HNE protein modification
3.1.2.1. Damaging effects. Protein carbonylation is usually seen as an undesired effect which exerts clear toxicological consequences by profoundly altering the biological functions of the adducted proteins (Fig. 7) [112] . Its overall cellular effect depends on the role played by the adducted proteins and can induce apoptosis when affecting signaling cascades involved in cell growth and differentiation [113] . In detail, the toxic effects exerted by HNE protein adducts can occur through two major mechanisms. Firstly, the adducts can alter the protein conformation inducing misfolding events with clear toxic outcomes especially when affecting structural proteins such as those involved in the cytoskeleton [114] . A clear example is provided by α-synuclein, which reacts with HNE forming protein adducts which are able to seed the α-synuclein amyloidogenesis by inducing conformation changes which are different from those seen in amyloid fibrils based on β-sheet stabilization [115] . A second mechanism affects enzymes and receptors and induces their substantial inactivation by masking nucleophilic residues which play key roles in the protein function. Among the numerous enzymes which are found to be affected by HNE carbonylation, two enzymatic classes are worthy of mention. The first group includes enzymes (such as Serine/Threonine-Protein Kinase AKT2) which are variously involved in the cellular response to oxidative stress and the carbonylation of which induces a vicious circle which progressively exacerbates the stress condition [116, 117] . The second class involves enzymes which assist the folding of other proteins, such as Protein Disulfide Isomerase (PDI) [118] , which are consequently unable to correctly fold, thus indirectly propagating the structural alterations exerted by HNE. With regard to receptor carbonylation, HNE usually induces an aberrant signaling of the adducted proteins by inhibiting or even endlessly stimulating them. An interesting example is provided by a very recent study revealing that the aberrant TRPV1-dependent regulation of coronary blood flow (CBF) observed in diabetic patients is ascribable to the formation of a covalent adduct between HNE and Cys621 of TRPV1 which is located on the pore and the modification of which inhibits TRPV1 currents thus contributing to the microvascular dysfunctions as seen in diabetic patients [119] .
3.1.2.2.
Protein HNE adduction as a protective and modulatory detoxifying mechanism. Even though the carbonylation of these proteins is usually seen as a toxic consequence induced by the HNE accumulation under stress conditions, it can also have protective and modulatory effects (Fig. 7) . A first protective mechanism can be rationalized by considering the general reversibility of these adducts which suggests that they can have a role similar to that of cysteinylation by protecting critical residues during severe stress conditions. Indeed, highly oxidative conditions can irreversibly oxidize the thiol functions into sulphinic and sulphonic acids by which the protein function is irremediably lost [120] , while HNE-induced covalent modifications of the thiol group can protect them from irreversible modifications allowing their restoration when the oxidative stress disappears. Clearly, such a protective mechanism would occur at the expense of temporarily inactivating the proteins. The possible protective roles of HNE are further substantiated by a recent study which revealed that a vast majority of HNE adducts shows a dynamic behavior and rapidly disappear in intact cells. In contrast, few protein adducts were found to be highly stable during the time thus suggesting that, along with the already mentioned selectivity of the residue's reactivity, there is also a selectivity in the adduct stability which is modulated by factors present only in intact and metabolically active cells and cannot be restricted to sole chemical factors [121] .
A second protective mechanism is seen in those proteins which possess extremely reactive residues and are richly carbonylated by HNE. When their concentration is largely higher than that of HNE, one may figure out that these reactive proteins have a sacrificial role since they are able to trap HNE almost completely with a minimal impact on its overall function even assuming that the adducted proteins lose their biological activities. Some abundant extracellular and cellular proteins such as albumin and actin have been identified as sacrificial substrates of HNE. The high reactivity of such protein is not only due to their abundance but also due to the presence of reactive and accessible cysteine residues. Albumin rapidly reacts with HNE (rate constant of 50.61 ± 1.89 M-1 s-1) and is the main reagent responsible for the rapid disappearance of HNE in serum. By considering a second-order reaction and a mean plasma concentration of 600 nmol/mL, the half-life of 10 nmol/mL of HNE in human plasma would be less than 17 s, which was then confirmed experimentally [108] . The high reactivity of HNE towards HSA is due to the presence of several accessible nucleophilic residues, among which Cys34 was found to be the most reactive [122] . The rate constant of Cys34 was found to be almost 1 order of magnitude higher than that of GSH, and such a different reactivity was explained by molecular modelling studies showing a markedly higher acidity of the thiol group of Cys34 in respect to that of GSH as above reported. Actin is another abundant protein which was found to be highly reactive towards HNE and also for this cellular protein the high reactivity is due to a cysteine residue, Cys374, which is characterized by a significant accessible surface and a substantial thiol acidity due to the particular surrounding microenvironment [123] .
The high reactivity and efficient quenching of some abundant proteins such as actin and albumin open a question regarding their potential role as non-enzymatic detoxifying agents of HNE and more in Fig. 6 . Reaction mechanism for the cross-talk between Lys6 and His68 of ubiquitin. Right figure depicts proximity between Lys6 and His68. Reproduced from ref. [110] with the permission of Elsevier. 
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general of lipid electrophilic break-down products. This view is reinforced by the fact that, at least for actin, the biological activity is not hampered by covalent binding with HNE [124] . Moreover, the covalent binding to cysteine residues is reversible and the free form could be restored by a transfer with GSH as below reported. Hence the accessible cysteine residues of albumin (Cys34) and actin (Cys374) which are not involved in disulfide bridge as well in the biological function of the proteins, seem to have the biological role of scavenging HNE before it can impact some nucleophilic sites of the protein whose adduction could compromise the protein function [125] . Furthermore, pathways activated upon HNE-induced carbonylation do not necessarily lead to aberrant signaling events as mentioned above but it can also play modulatory roles as exemplified by those reported for glutamate-cysteine ligase. This enzyme which catalyzes the ratelimiting step in GSH biosynthesis was found to be significantly activated by the HNE carbonylation which affects a cysteine residue of its modulatory subunit (Cys35). Such a post-translational regulation can clearly influence the GSH homeostasis increasing the GSH level (and the consequent detoxification effects) during oxidative stress [126] .
Finally, HNE has been found to form cysteine adducts on the protein Keap-1 (Kelch-like ECH-associated protein 1), which alters its conformation inducing the release of Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), which is subsequently exported to the nucleus [127] . This transcription factor induces antioxidant response element-dependent genes and upregulates several detoxifying enzymes, like GSTs, AKR and ALDH. Given this protective pathway activated by HNE, studies have been focusing on the protective role the aldehyde might have. Cardiomyocytes incubated with a sublethal concentration of HNE showed resistance against toxic concentrations of HNE due to GSH biosynthesis after Nrf2 translocation [128] . The same cardioprotective effect was found in mice after intravenous administration of HNE. In human colon cancer cells, KEAP-1 was silenced in order to elevate Nrf2 levels. Levels of different AKR enzymes were subsequently increased and these cells were more resistant to HNE than the control [129] . Recently, a slightly different mechanism was described to induce GSTA4 expression, where oncogenic transcription factor AP-1 containing the components c-Jun and Nrf2 was activated upon HNE exposure in a model for colorectal carcinogenesis [31] . Contrarily, another study showed that HNE exposure led to a reduced GSH concentration in epithelial cells [130] . After treatment with N-acetylcysteine (NAC), enzymes involved in GSH biosynthesis were upregulated by Nrf2, protecting the cells from HNE-induced apoptosis. These studies show that, at a balanced concentration, HNE can exhibit protective effects via the Nrf2 transcription pathway.
Proteomic study for identifying HNE protein targets
The advent of high resolution MS and its application in proteomics has greatly furthered our knowledge of the non-enzymatic fate of HNE and, in particular, of the reactions of HNE with nucleophilic macromolecules such as proteins and DNA. From an analytical point of view, identifying HNE-adducts is quite challenging due to the fact that such analytes are heterogeneous and present in a negligible amount, thus requiring a suitable sample preparation coupled to a highly sensitive and specific MS method. A great advancement in this field has been reached by using novel sample preparation strategies aimed at selectively isolating HNE modified proteins or peptides. Such strategies can be divided into two groups, the first based on modified HNE and the second on unmodified HNE. Methods belonging to the first group use modified HNE such as HNE containing a terminal alkyne group which, once HNE reacts with proteins, is tagged by click chemistry with biotin (Fig. 8 ). The adducted proteins are then separated by using an avidin based resin and identified by bottom-up MS [131] . Such analytical strategies work well and are quite selective and sensitive when identifying the biological targets of HNE but are clearly limited to in vitro systems such as cell cultures or tissue preparations and cannot be applied to ex-vivo conditions. So far, some in vitro studies have been reported and based on the identified protein targets, the biological effect of HNE has been explained. As an example, Chacko et al. studied the molecular mechanisms through which HNE induces a significant decrease in the oxidative burst response and phagocytosis of neutrophils [132] . Mass spectrometric analysis of alkyne-HNE treated neutrophils followed by click chemistry detected modification of approximately 100 cytoskeletal, metabolic, redox and signaling proteins that are critical for the oxidative burst mediated by NADPH oxidase. A similar approach has recently been applied to the identification of the HNE modified platelet proteins [133] .
Another approach widely used to identify HNE adducted proteins is that based on the use of tagged derivatizing agents which once bound with the Michael adducts between HNE and proteins/peptides, are then fished out by using a suitable affinity stationary phase (Fig. 9) . Enrichment can be carried out at protein or peptide level. Biotin hydrazide is an example of tagged derivatizing agent; it reacts with the carbonyl group of HNE forming the corresponding hydrazone derivative which, after a reducing step carried out to prevent hydrolytic cleavage, is enriched by using a streptavidin based stationary phase. Aldehyde/keto reactive group (ARP) is also used as tagged derivatizing agent; by reacting with the carbonyl group of HNE it forms the corresponding aldoxime derivative which does not require the reducing step being a stable reaction product. The approach based on tagged derivatizing agents has the advantage that can be applied to ex vivo samples but the disadvantage is that it can only identify Michael adducts but not reaction products lacking the carbonyl moiety (Schiff base and cross links). Several proteomic papers based on such a strategy have been reported using both in vitro and ex-vivo samples. Tzeng and Maier applied the strategy to identify the adducted proteins in liver mitochondrial proteome. Pathway analysis indicated that proteins associated with metabolic processes, including amino acid, fatty acid, and glyoxylate and dicarboxylate metabolism, bile acid synthesis and TCA cycle, showed enhanced reactivity to HNE adduction. In contrast, proteins associated with oxidative phosphorylation displayed retardation toward HNE adduction. Galligan et al. identified HNE liver protein targets in a 6-week murine model for alcoholic liver disease (ALD) [134] .
The two above mentioned approaches have identified in in vitro (cells, tissue) and ex vivo conditions a list of proteins targeted by HNE. Such information, beside permitting a better explanation of the biological activity of HNE also underlies the concept that HNE does not randomly bind the whole proteome but selectively binds proteins characterized by a certain reactivity. This important aspect has been further addressed by quantitative and semi-quantitative chemo proteomic studies as well as by molecular modelling studies as above described. By using a semi-quantitative chemoproteomic method named competitive activity-based profiling method, Wang et al. have measured the reactivity of HNE against more than a thousand cysteines in parallel in the human proteome [135] . A set of proteins reactive towards HNE characterized by the presence of discrete sites of hypersensitivity or "hot spots" was identified among which Cys22 of ZAK was found to be highly reactive. ZAK is a kinase, activating JNK, ERK, and p38 MAPK pathways in both cancer and inflammation. HNE binding inhibits ZAK activity thus limiting the extent of JNK activation caused by oxidative stress, which could help certain cell types, such as tumor and immune cells, to survive in the presence of high levels of reactive oxygen species.
HNE Protein adduct stability and metabolic turnover
Proteins modified by HNE show increased proteolytic susceptibility for removal by the proteasome. When the HNE modification is increased, involving extensive cross-links, HNE modified proteins become poor substrates for proteasomal degradation, leading to an accumulation of non-degradable compounds. A more extensive HNE adduction inhibits the proteasome, and further impairs cellular protein turnover [136] . By using novel chemoproteomic approaches able to measure the semi-quantitative amount of the adducted protein, it has been demonstrated that HNE-protein adducts undergo a rapid metabolic turnover which also involves a pathway independent of the proteosomal system and which requires an intact cellular environment. In this regard Yang et al. recently developed a quantitative and sensitive strategy capable of depicting sub-proteome susceptibility to HNE injury in the hepatic mitochondrion [121] . By incubating HNE with RKO cells, they found that about 87% of quantifiable HNEadducted proteins showed at least a 2-fold decrease over the course of 4 h. Such a turnover was attributed to some unknown repair or reversion processes, rather than to an overall protein degradation, as confirmed by the fact that the turnover of HNE-protein adducts in cells was not affected by co-incubation with the proteasome inhibitor MG132. Nevertheless, some HNE adducts were found stable over the 4 h of incubation. As an example, of four cysteine residues modified by HNE on FAM120A, Cys919, Cys1088, and Cys1103 showed dramatic decreases in S-alkylation after 1-4 h recovery periods, whereas Salkylation on Cys531 remained almost unchanged. It was also found that the rapid turnover requires an intact cellular environment since protein alkylation did not change significantly in cell lysates. The authors concluded that HNE-induced protein carbonylation is highly dynamic in intact cells and that adduct turnover rates vary in a sitespecific manner. Accordingly, Just et al. found that the HNE adduct with the α7 subunit of the 20 S proteasome is quite unstable in neonatal foreskin fibroblast by significantly reducing within 6 h and that the rapid turnover was not affected by inhibition of either the proteasomal system or lysosomal autophagy and was found to constitute a spontaneously unstable linkage of HNE to the proteasomal subunit [137] .
Taken together these studies well indicate that HNE-protein adducts are quite unstable and undergo a rapid biotransformation although some protein adducts remain stable. Such rapid turnover can be partially explained by considering the degradation catalyzed by the proteosomal system although an independent pathway should be considered. One possible mechanism of the rapid HNE-protein degradation adducts is that mediated by GSH which removes the HNE adduct from the protein due to the reversibility of the Michael adduct which involves all nucleophilic residues and is added to the well-known lability of imino adducts involving only lysine residues. Several papers have described, using direct and indirect evidences, the ability of GSH to remove HNE from proteins. HNE was reported to inhibit glutathione peroxidase in a concentration-dependent manner, an effect which was almost completely (89%) prevented by 1 mM glutathione added to the incubation mixture 30 min after HNE spiking [138] . Direct evidence of the ability of GSH to remove HNE from the covalent adduct has been reported by Carbone et al. who found that 4 mM GSH removed HNE from the PDI protein adducts [139] . Korotchkina et al. demonstrated the reversibility of HNE induced protein inactivation in cells [140] . When HepG2 cells were treated with 1 mM HNE, the α-keto acid dehydrogenase complex activities were found to be significantly reduced and then partially restored by treating cells with 3 mM for 30 min. The enzymatic activities further increased by prolonging the incubation to 120 min thus indicating that HNE-induced inactivation of α-keto acid dehydrogenase complexes could be reversed in a timedependent manner by cysteine.
The fate of HNE protein adducts is still under investigation and represents a quite interesting field of research.
Adducts with nucleic acids
Due to its electrophilicity, HNE can also condense with the four ring bases in nucleic acids showing a reactivity which parallels their nucleophilicity [141] . In fact, the major detected adduct involves the guanine ring which condenses with HNE to give the four possible diastereomers of the exocyclic 1,N2-propano-dG adducts (HNE-dG) through a Michael addition. When epoxidized to 2,3-epoxy-4-hydroxynonanal (EHN), it can also condense with adenine to yield two major adducts, namely 1,N6-ethenodA (edA) and 7-(1′,2′-dihydroxyheptyl)-l, Fig. 8 . Reaction scheme between protein adduct involving HNE containing an alkynyl tail and biotin azide using click chemistry. So adducted proteins can then be separated using avidin. Fig. 9 . Derivatizing agents to identify HNE adducts based on biotin hydrazide and aldehyde/keto reactive probe.
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N6-etheno-dA (DHHedA) [142] . With a reactivity which is largely influenced by stereochemistry, the DHHedA adduct can then open and liberate the free aldehyde which can cyclize to give the corresponding hemiacetal ring or can condense with the opposite guanine base to form the carbinolamine intermediate which then dehydrates to yield crosslink adducts stabilized by an imino function or by a tetrahydrofuran ring. The capacity to accommodate bulky moieties as in the case of hemiacetals or to arrange the reactive aldehyde close to the opposite base ring can clearly rationalize the observed stereospecific formation of such adducts. When unable to cross-link with adjacent bases, the reactive aldehyde can condense with amino groups from peptides or proteins forming mixed HNE-DNA-protein adducts [143] .
With regard the biological implications of the HNE-DNA adducts, several studies showed that they are genotoxic and mutagenic by inducing the G·C to T·A transversions, while nucleotide excision repair (NER) was found to be the major pathway involved in repairing 4-HNE-DNA adducts [144] . Notably, kinetic studies revealed competitive effects in the repairing of DNA adducts by HNE and acrolein since the former are repaired markedly more rapidly than the latter the repairing of which appears to be inhibited by HNE-dG adducts. This can explain why the level of the HNE-DNA adducts was found to be almost unaltered even in tissues with elevated oxidative stress (e.g. brain tissue from AD patients), while the acrolein-DNA adducts show increased levels [145] . Even though the above described cross-link adducts are reversible and appear to be present at low levels in vivo, they can induce severe genotoxic implications especially because of their difficult reparation which requires the cooperation of multiple enzymes belonging to different pathways. The EHN-DNA adducts are even more mutagenic than those which come from HNE and were detected in rodent and human cancer tissues [146] .
Adducts with endogenous peptides
Besides the already mentioned adducts with GSH, HNE can condense with other peptides among which the histidine containing peptides play a major role [147] . Carnosine, which represents the prototype of these small molecules, is able to stably quench HNE through a concerted mechanism which resembles that already described for ubiquitin and involves firstly the amino terminal group to give the imino intermediate and then the imidazole ring which reacts with the β carbon atom to yield the corresponding Michael adduct [148] . The already mentioned reversibility of the imino derivative can explain the selectivity of carnosine towards α,β unsaturated carbonyls which is also ascribable to the fact that the imidazole alone is unable to give the Michael addition [149] . The histidine containing peptides also include a set of carnosine analogues which differ in the length of the amino terminal residue (e.g. homocarnosine, [150] ), in the methylation of the imidazole ring (e.g. anserine) or in the modifications in the carboxyl group (e.g. carnosinamide). HNE quenching capacity is also shown by several dipeptides in which β alanine is replaced by proteinogenic residues [151] . All these dipeptides show the same quenching mechanism already described for carnosine with a reactivity towards HNE which can be related to their nucleophilicity, flexibility and lipophilicity as evidenced by a recent comparative study [152] . As a rule, all these analogues show a quenching activity lower than carnosine, even though some of them retain a notable reactivity (as shown by anserine and carnosinamide). The beneficial effects exerted by carnosine in several animal models have attracted huge interest in the last few years even though carnosine has a restricted medicinal role in humans since it is rapidly hydrolyzed in human plasma by a specific dipeptidase [153] . This means that carnosine can elicit its protective effect only in those tissues which express the carnosine synthase enzyme such as skeletal muscle, brain and heart [154] . This prompted the development of several synthetic carnosine analogues which maintain quenching activity and selectivity while showing favorable pharmacokinetic profiles and the analysis of which goes beyond the scope of this review [155] . Another endogenous peptide which showed a HNE quenching capacity is the tripeptide Gly-His-Lys (GHK) even though it possesses a lower reactivity which is explainable by considering unfavorable conformational properties of GHK [156] .
Again, insulin and angiotensin II are two (longer) peptides which yield stable adducts with HNE endowed with impaired physiological functions. In detail, adducted insulin reveals a markedly reduced hypoglycemic effect thus suggesting that these covalent modifications might be involved in the pathogenesis of insulin resistance [157] , while modified angiotensin II might be unable to interact with its receptor or might inhibit aminopeptidase A, which converts Ang II into Ang III [158] .
HNE and small endogenous molecules
Reactions with cofactors and vitamins
Along with the above-mentioned dipeptides, other small endogenous molecules are able to stably condense with HNE. In detail, some cofactors and vitamins (thiamine, pyridoxamine and lipoic acid) are found to react with HNE yielding covalent adducts which contribute to their overall physiological functions [159] . Among them, pyridoxamine has attracted great interest in the last few years for its therapeutic applications and indeed it reached clinical phase III for diabetic nephropathy by NephroGenex Inc [160] . The potential reactivity of ascorbic acid is still questioned and, even though a possible Michael addition between HNE and activated C-H groups of ascorbic acid was reported, its protective effect against HNE can be ascribed to its modulating effects on multidrug resistant protein (MRP)-mediated transport of GSH-HNE conjugate metabolites [161] .
Reaction with hydrogen sulphide (H 2 S)
Recently, a detoxification mechanism of HNE driven by hydrogen sulphide, an endogenous vascular gasotransmitter and neuromodulator, was proposed by observing that NaHS, a H 2 S generator, dose-dependently inhibited HNE induced cell toxicity. Moreover, hydrogen sulphide was found to inhibit HNE protein modification both in in vitro and cells experiments. Although no reaction products were identified and characterized, a reaction mechanism was proposed involving the formation of 3-mercapto-4-hydroxy-nonanal as an initial product which can react with a second HNE molecule [162] . The scavenging effect of hydrogen sulphide was finally underlined by considering its lipophilic nature and the fact that HNE is formed and preferentially distributes in biomembranes.
Reaction with aminophospholipids
In 90's, Guichardant et al. firstly reported, in in vitro conditions, the covalent reaction between HNE and phospholipids containing amino groups and particularly phosphatidylethanolamine (PE). The reaction products were then identified and characterized by LC-MS as the Michael adduct plus a minor Schiff base adduct, which was partly cyclized as a pyrrole derivative via a loss of water. By contrast, phosphatidylserine was found to poorly react with HNE, producing only a small amount of Michael adduct while the Schiff-base was nondetectable [163] . The Schiff base as the main reaction product between HNE and PE was then confirmed after oxidation (UV irradiation and Fe 2+ /ascorbate) of cerebral cortex homogenates [164] . The first study reporting the formation of Michael adducts between HNE and PE in biological matrices was published by Bacot et al. who reported the formation of HNE-PE Michael adducts in human blood platelets in response to oxidative stress and in retinas of streptozotocin-induced diabetic rats [165] . Adducts were identified by using a sensitive GC-MS negative ion chemical ionization (NICI) method after cleavage of the phosphodiester bonds and derivatization of the ethanolamine-alkenal moiety. HNE-PE Michael adduct was then found to be formed, together with other PE lipid aldehydes adducts, in high-density lipoproteins exposed to myeloperoxidase and to induce monocyte adhesion to cultured endothelial cells [166] . The effects of such covalent modification on membrane function was then investigated by O. Jovanovic et al. who demonstrated that HNE driven modification of membrane induces changes of the biophysical properties of the membrane such as membrane order parameter, boundary potential and membrane curvature [167] . Taken together these data well demonstrate that HNE react with PE forming both Michael adduct and Schiff base and that this last is a favorable product due to the anhydrous environment. Some results also indicate that such reaction have a damaging effect by inducing an inflammatory response and changing the biological properties of the membrane. More studies are needed to establish whether this reaction occurs in in vivo conditions where other nucleophilic substrates such as proteins can compete with PE. However, it should be noted that the HNE reaction with PE in the cell membrane could be favoured due to several factors: 1) the absence of the GSH detoxifying system, 2) the lipophilic milieu which stabilizes the Schiff base reaction product and 3) the PE membrane localization which is closed to the site of HNE formation [168] .
Conclusion and future perspectives
Following the first paper on HNE metabolism in hepatoma cell lines published at the end of the 1980s and although the routes of some phase I and phase II metabolites still need to be elucidated, the main enzymatic detoxification reactions of HNE have been clarified in in vitro and animal models. Our knowledge of metabolic detoxification has grown in parallel with the advent of novel analytical instruments such as LC-MS and GC-MS and sample preparation procedures which have permitted the identification, characterization and quantification of both phase I and II metabolites in biological matrices. In particular, phase II metabolites involving GSH and mercapturic adduction can now be easily detected and fully characterized by LC-ESI-MS while HNE and phase I metabolites are measured by GC-MS after a suitable derivatization reaction. Untargeted analytical methods have also permitted the identification of unpredicted metabolites and in particular adducts with small molecules such as peptides (carnosine and histidine containing peptides) and phospholipids. Thanks to such recent analytical approaches and by using radioactive and stable isotopes of HNE, as recently published by the group of Gueraud, the HNE metabolism of rodents has been quite well addressed, also from a quantitative point of view. By contrast more studies are needed for a better clarification of the HNE metabolism of humans in different physio-pathological conditions and to trace the HNE sources (endogenous and dietary pathways).
In recent years some studies on the biological effects of HNE metabolites have been carried out, demonstrating that they are not inactive and devoid of biological effects but in some cases have a potentiated effect in respect to HNE, as in the case of the proinflammatory action of GS-HNE adducts. These studies are of great interest especially considering that GS-HNE adducts and in particular the urinary mercapturic derivatives are well dosed in humans [169] , are increased by some conditions and habits such as smoking [170] and can be modulated by supplements such as vitamin C intake [161] .
Although the main metabolic fate of HNE is enzymatically driven, great interest is focused on the non-enzymatic reactions involving biomolecules such as proteins and phospholipids. Interest in this type of metabolic fate has grown in parallel with the advent of highly sensitive and specific MS methods which have permitted the identification of unknown covalent adducts and in particular proteomic techniques for the identification of HNE protein adducts. Another aspect stimulating the interest in a non-enzymatic fate of HNE is due to the biological effects of the protein adducts and that protein adduction is not a random process but is quite selective, targeting proteins with some specific features. We still need to better understand the biological effects of protein HNE adduction which depend on the identity of the target proteins. Some proteins, such as actin and albumin can act as detoxifying molecules. Others, such as α-synuclein [171] and lipid phosphatase PTEN [172] , induce a damaging effect while others, glutamate-cysteine ligase [126] and transcription factor Nrf2 [128] , modulate a protective effect and in particular an increased antioxidant response. Hence, at least in some cases, protein adduction is not a random process involving the HNE fraction escaping the enzymatic metabolism but more likely an endogenous pathway required for HNE detoxification or cell signaling. In other words, HNE stimulates cells for an antioxidant defence, induces the elimination of damaged cellular components or even serves to protect of the organism by inducing apoptosis in severely injured cells.
Clearly we should also consider a fraction of HNE, targeting sensitive proteins and acting as a damaging mediator, whose scavenging by a boosted enzymatic or non-enzymatic detoxification, this last mediated by covalent sequestering agents, could represent a promising therapeutic approach [105] .
Another important aspect requiring future investigations deals with the molecular and presumably enzymatic mechanisms regulating the fast disappearance of HNE adducted proteins, a process whose elucidation will permit a better understanding of the biological activity of HNE and the identification of novel targets to modulate their activity.
Taken together these studies well indicate that the non-enzymatic protein adduction of HNE is a quite complex mechanism which depends on several factors such as i) the reactivity of the nucleophilic sites which regulate which proteins of the whole proteome are preferentially modified, ii) the absolute amount of the proteins, iii) the stability of the adducts. Several questions arise and in particular whether the covalent adduction by some abundant and reactive proteins such as albumin and actin is an endogenous non-enzymatic detoxification process or an unwanted protein modification.
